Finally, we identified genes associated with AD susceptibility that interact with the key targets of menopause hormone replacement drugs, specifically the ESR1, and ESR2 genes, as well as GPER1(G protein-coupled estrogen receptor1), providing valuable insights into potential therapeutic avenues. This evidence concerns the gene ESR2 and Alzheimer disease.